A number of investment brokers have recently updated their price targets on shares of BioPharmX Corporation (BPMX). According to the latest broker reports outstanding on Monday 9th of May, 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts “neutral”, 0 analysts “sell” and 0 analysts “strong sell”.

Most recent broker ratings

04/15/2016 – Maxim Group began new coverage on BioPharmX Corporation giving the company a “buy” rating. They now have a USD 3 price target on the stock.

04/07/2016 – H.C. Wainwright began new coverage on BioPharmX Corporation giving the company a “buy” rating. They now have a USD 3 price target on the stock.

09/04/2015 – Sterne Agee began new coverage on BioPharmX Corporation giving the company a “buy” rating. They now have a USD 3.5 price target on the stock.

09/03/2015 – CRT Capital began new coverage on BioPharmX Corporation giving the company a “buy” rating.

The share price of BioPharmX Corporation (BPMX) was up +3.07% during the last day of trading, with a day high of 0.80. 59618 shares were traded during the last session.

The stock’s 50 day moving average is 0.99 and its 200 day moving average is 1.30. The stock’s market capitalization is 16.87M. BioPharmX Corporation has a 52-week low of 0.73 and a 52-week high of 4.50.

View other investors thoughts on BioPharmX Corporation with our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.